American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Dublin, Oct. 20, 2016 -- Research and Markets has announced the addition of the "The Overview of Japanese Pharmaceutical Industry ver2016" report to their offering.
This report talks about the overview of Japanese pharmaceutical industry. By reading this report, readers will understand overall picture about the industry, from various aspects.
Domestic pharmaceutical market size is said to be about 6.9 trillion yen at the ex-manufacturer level, and about 10.8 trillion yen in terms of drug price. While the market size of non-prescription drugs is slightly declining, that of ethical drugs is on the rise, accounting for about 90% of the whole market.
Key Topics Covered:
1. Summary
2. Definition of pharmaceutical industry
3. Classification of pharmaceutical industry
4. Definition of drugs
5. Distribution structure of drugs
6. Pharmaceutical market size in Japan
7. Regulation of related laws
8. Related industry groups
9. High profitability
10. Long history and family management
11. Difficulty of new drug development
12. Structural risk peculiar to the pharmaceutical industry, Patent cliff
13. Disclosure of pipeline
14. Low penetration of vertical integration
15. Changing business environment
16. Companies striving for structural reform
17. Differences between Japanese and foreign companies
18. Characteristics of Labour market
19. Concentration of major companies in member countries of the Organization for Economic Co-operation and Development (OECD)
20. Reference: Comparison with the U.S. and European countries
For more information about this report visit http://www.researchandmarkets.com/research/k4qjk2/the_overview_of
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals
